COGNITION THERAPEUTICS
0.5202
07-November-24 15:59:33
15 minutes delayed
Stocks
+0.0204
+4.08%
Today's range
0.5081 - 0.5301
ISIN
N/A
Source
NASDAQ
-
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
15 Mar 2024 07:30:59 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
14 Mar 2024 16:05:15 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
11 Mar 2024 20:16:05 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Proposed Public Offering of Common Stock
11 Mar 2024 16:05:16 By Nasdaq GlobeNewswire
-
06 Mar 2024 07:30:00 By Nasdaq GlobeNewswire
-
Cognition Therapeutics to Present at the TD Cowen Health Care Conference
26 Feb 2024 07:30:59 By Nasdaq GlobeNewswire
-
06 Feb 2024 08:47:22 By Nasdaq GlobeNewswire
-
Cognition Therapeutics CEO Issues Letter to Shareholders
04 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
16 Nov 2023 07:30:35 By Nasdaq GlobeNewswire
-
15 Nov 2023 07:30:48 By Nasdaq GlobeNewswire
-
07 Nov 2023 07:30:25 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
02 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
27 Oct 2023 07:30:15 By Nasdaq GlobeNewswire
-
24 Oct 2023 16:30:41 By Nasdaq GlobeNewswire
-
16 Oct 2023 07:30:00 By Nasdaq GlobeNewswire
-
07 Sep 2023 07:45:45 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Announces Participation in Upcoming September Conferences
30 Aug 2023 08:00:31 By Nasdaq GlobeNewswire
-
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
08 Aug 2023 07:00:18 By Nasdaq GlobeNewswire
-
02 Aug 2023 07:30:00 By Nasdaq GlobeNewswire
-
11 Jul 2023 07:30:12 By Nasdaq GlobeNewswire